Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGWBO:RHK -0.77%81 PS Ratio is 0.51 as of Jul. 31, 2026, which is 30% below its 10-year median of 0.73. GuruFocus rates WBO:RHK with a GF Score™ of 81/100 and a GF Value™ of €13.57. The stock has 3 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks better than 78.57% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Rhoen Klinikum AG's share price is €12.90.
Rhoen Klinikum AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €25.51. Hence, Rhoen Klinikum AG's PS Ratio for today is 0.51.
Good Sign:
Rhoen Klinikum AG stock PS Ratio (=0.51) is close to 2-year low of 0.46.
The historical rank and industry rank for Rhoen Klinikum AG's PS Ratio or its related term are showing as below:
WBO:RHK'
s PS Ratio Range Over the Past 10 Years
Min: 0.44 Med: 0.73 Max: 1.75
Current: 0.52
During the past 13 years, Rhoen Klinikum AG's highest PS Ratio was 1.75. The lowest was 0.44. And the median was 0.73.
WBO:RHK's PS Ratio is ranked better than 78.57% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs WBO:RHK: 0.52
During the past 12 months, the average Revenue per Share Growth Rate of Rhoen Klinikum AG was 3.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.40% per year.
During the past 13 years, Rhoen Klinikum AG's highest 3-Year average Revenue per Share Growth Rate was 16.20% per year. The lowest was -15.40% per year. And the median was 3.70% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Rhoen Klinikum AG PS Ratio Related Terms
Rhoen Klinikum AG PS Ratio Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Rhoen Klinikum AG's Share Price of today is €12.90. Rhoen Klinikum AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €25.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Rhoen Klinikum AG (WBO:RHK) has a PS Ratio of 0.51 as of Jul. 31, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rhoen Klinikum AG and its competitors. This is 30% below median its historical median of 0.73. Over the past decade, Rhoen Klinikum AG's PS Ratio has ranged from 0.44 to 1.75. According to the industry distribution chart, Rhoen Klinikum AG ranks #141 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 21.4%.
Is Rhoen Klinikum AG's PS Ratio too high?
Rhoen Klinikum AG's current PS Ratio of 0.51 is 30% below median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.75. The Healthcare Providers & Services industry median PS Ratio is 1.47. Rhoen Klinikum AG's value of 0.51 is 65.3% below this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #141 out of 658 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #141 out of 658 companies for PS Ratio. This places Rhoen Klinikum AG in the top 21% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.47. Rhoen Klinikum AG's value of 0.51 is 65.3% below this benchmark. Historically, Rhoen Klinikum AG's own PS Ratio has ranged from 0.44 to 1.75 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 1.47, Rhoen Klinikum AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current PS Ratio of 0.51 is 65.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current PS Ratio is 0.51, which is 30% below median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current PS Ratio of 0.51. The stock's GF Value™ is €13.57, compared to a current price of €12.90 — trading 4.9% below its estimated fair value. The current PS Ratio is 0.51, which is 30% below median its 10-year median of 0.73 and 65.3% below the Healthcare Providers & Services industry median of 1.47. Rhoen Klinikum AG's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current PS Ratio is 0.51 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of €12.90 is trading 4.9% below its estimated GF Value™ of €13.57.
Key valuation signals for WBO:RHK:
PS Ratio: 0.51 (30% below median its 10-year median of 0.73)
GF Value™: €13.57 vs. price of €12.90 (4.9% below fair value)
Industry Position: 65.3% below the Healthcare Providers & Services median (#141 of 658)
No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
81GF Score
Get the complete analysis for WBO:RHK
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:RHK has been successfully added to your 
